HAZNEDAROĞLU, İ. C. Et Al. 2010. The Gray-Zone Concept, Suboptimal Response to Imatinib, Shall be Removed from the ELN-CML Recommendations. UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.20, no.2 , 25-26.

HAZNEDAROĞLU, İ. C., Koca, E., AKSU, S., GÖKER, H., SAYINALP, N., BÜYÜKAŞIK, Y., ... ÖZCEBE, O. İ.(2010). The Gray-Zone Concept, Suboptimal Response to Imatinib, Shall be Removed from the ELN-CML Recommendations. UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.20, no.2, 25-26.

HAZNEDAROĞLU, İBRAHİM Et Al. "The Gray-Zone Concept, Suboptimal Response to Imatinib, Shall be Removed from the ELN-CML Recommendations," UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.20, no.2, 25-26, 2010

HAZNEDAROĞLU, İBRAHİM C. Et Al. "The Gray-Zone Concept, Suboptimal Response to Imatinib, Shall be Removed from the ELN-CML Recommendations." UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.20, no.2, pp.25-26, 2010

HAZNEDAROĞLU, İ. C. Et Al. (2010) . "The Gray-Zone Concept, Suboptimal Response to Imatinib, Shall be Removed from the ELN-CML Recommendations." UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.20, no.2, pp.25-26.

@article{article, author={İBRAHİM CELALETTİN HAZNEDAROĞLU Et Al. }, title={The Gray-Zone Concept, Suboptimal Response to Imatinib, Shall be Removed from the ELN-CML Recommendations}, journal={UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI}, year=2010, pages={25-26} }